• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COX-2基因多态性与非小细胞肺癌易感性之间的关联。

Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.

作者信息

Zhang Tiancheng, Li Jing, Xia Tian, Zhang Nan, Zhang Yaozhou, Zhao Jian

机构信息

International Joint Cancer Institute, The Second Military Medical University Shanghai, China.

Tianjin East Innovation Biotechnology Limited Company Tianjin, China.

出版信息

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3168-73. eCollection 2015.

PMID:26045835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4440144/
Abstract

AIM

To explore the association between COX-2 polymorphisms and non-small cell lung cancer (NSCLC) susceptibility.

METHODS

We collected fasting peripheral venous blood from 60 cases with NSCLC and 62 healthy controls through physical examinations, and applied PCR-RFLP to analyze COX-2 polymorphisms of two groups.

RESULTS

With respect to detecting COX-2 rs689466 and rs5275 polymorphisms, the distribution frequency of mutant genotype AA of COX-2 rs689466 in case group was higher than that in control group, which possessed significant difference between two groups (P<0.05). Carriers with AA genotype were 4.05 times at risk of NSCLC than those with GG genotype (P = 0.04, OR=4.05, 95% CI=1.14-14.43). The distribution of mutant genotype CC of COX-2 rs5275 was different between two groups, and carriers with genotype CC were at 5.70 times higher risk of NSCLC than those with genotype TT. After corrected by sex, gender, smoking and drinking factors, AA genotype of COX-2 rs689466 and CC genotype of COX-2 rs5275 still contributed to increased risk of NSCLC (OR=4.22, 95% CI=1.10-16.17, OR=6.95, 95% CI=1.27-38.11). After analyzed of linkage disequilibrium (LD) and haplotypes of alleles in two SNPs, the distribution frequency of A-C haplotype in case group was higher than that in control group, with significant difference between two groups (P<0.05). After corrected by sex, gender, smoking and drinking factors, statistical difference was still found in the total distribution of A-C haplotype between two groups (P=0.03, OR=6.11, 95% CI=1.16-32.2).

CONCLUSIONS

COX-2 rs689466 and rs5275 polymorphisms may be related to NSCLC susceptibility. And A-C haplotype might be a susceptibility haplotype for NSCLC.

摘要

目的

探讨COX - 2基因多态性与非小细胞肺癌(NSCLC)易感性之间的关联。

方法

通过体检收集60例NSCLC患者和62例健康对照者的空腹外周静脉血,应用聚合酶链反应 - 限制性片段长度多态性(PCR - RFLP)分析两组的COX - 2基因多态性。

结果

在检测COX - 2 rs689466和rs5275多态性方面,病例组中COX - 2 rs689466突变基因型AA的分布频率高于对照组,两组间差异有统计学意义(P<0.05)。AA基因型携带者患NSCLC的风险是GG基因型携带者的4.05倍(P = 0.04,OR = 4.05,95%CI = 1.14 - 14.43)。COX - 2 rs5275突变基因型CC在两组间的分布不同,CC基因型携带者患NSCLC的风险比TT基因型携带者高5.70倍。经性别、吸烟和饮酒因素校正后,COX - 2 rs689466的AA基因型和COX - 2 rs5275的CC基因型仍与NSCLC风险增加有关(OR = 4.22,95%CI = 1.10 - 16.17,OR = 6.95,95%CI = 1.27 - 38.11)。对两个单核苷酸多态性(SNP)的等位基因进行连锁不平衡(LD)和单倍型分析后,病例组中A - C单倍型的分布频率高于对照组,两组间差异有统计学意义(P<0.05)。经性别、吸烟和饮酒因素校正后,两组间A - C单倍型的总体分布仍存在统计学差异(P = 0.03,OR = 6.11,95%CI = 1.16 - 32.2)。

结论

COX - 2 rs689466和rs5275多态性可能与NSCLC易感性有关。且A - C单倍型可能是NSCLC的易感单倍型。

相似文献

1
Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.COX-2基因多态性与非小细胞肺癌易感性之间的关联。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3168-73. eCollection 2015.
2
Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.缺氧诱导因子-1α 多态性与非小细胞肺癌易感性的关联。
Transl Res. 2012 Jan;159(1):42-50. doi: 10.1016/j.trsl.2011.09.003. Epub 2011 Oct 8.
3
Relationship between genetic polymorphisms of DNA ligase 1 and non-small cell lung cancer susceptibility and radiosensitivity.DNA连接酶1基因多态性与非小细胞肺癌易感性及放射敏感性的关系。
Genet Mol Res. 2015 Jun 26;14(2):7047-52. doi: 10.4238/2015.June.26.14.
4
Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.五种环氧化酶-2(COX-2)基因多态性与乳腺癌风险:基于19项病例对照研究的最新荟萃分析
Med Oncol. 2015 Jan;32(1):397. doi: 10.1007/s12032-014-0397-6. Epub 2014 Nov 30.
5
Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.台湾地区环氧化酶2基因分型对乳腺癌的贡献评估。
Anticancer Res. 2014 Nov;34(11):6711-6.
6
The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.COX-2 多态性与铂类化疗治疗晚期非小细胞肺癌患者血液学毒性的关系。
PLoS One. 2013 Apr 19;8(4):e61585. doi: 10.1371/journal.pone.0061585. Print 2013.
7
[A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].[非小细胞肺癌中CASP9基因的表达及其多态性分布研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):59-62.
8
Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.肿瘤坏死因子-α基因多态性与非小细胞肺癌易感性及严重程度的关联
Lung Cancer. 2006 Apr;52(1):15-20. doi: 10.1016/j.lungcan.2005.11.011. Epub 2006 Feb 14.
9
[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].基质金属蛋白酶-3基因多态性与非小细胞肺癌遗传易感性及淋巴结转移的相关性
Ai Zheng. 2005 Mar;24(3):305-10.
10
Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese.PTGS2 和 CYP2E1 基因多态性与中国东北地区肺癌风险的协同关联。
PLoS One. 2012;7(6):e39814. doi: 10.1371/journal.pone.0039814. Epub 2012 Jun 25.

引用本文的文献

1
COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.环氧化酶-2 rs5275和rs689466基因多态性与肺癌风险:一项遵循PRISMA标准的荟萃分析。
Medicine (Baltimore). 2018 Aug;97(35):e11859. doi: 10.1097/MD.0000000000011859.

本文引用的文献

1
[A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].[一名晚期胆囊癌手术后复发接受S-1和吉西他滨治疗的长期存活者]
Gan To Kagaku Ryoho. 2010 Oct;37(10):1979-81.
2
Expression of phosphorylated Akt in patients with small cell carcinoma of the lung indicates good prognosis.磷酸化 Akt 在小细胞肺癌患者中的表达表明预后良好。
Pathol Int. 2010 Nov;60(11):714-9. doi: 10.1111/j.1440-1827.2010.02594.x. Epub 2010 Oct 6.
3
Optimal cutoff points of CYFRA21-1 for survival prediction in non-small cell lung cancer patients based on running statistical analysis.基于运行统计分析的 CYFRA21-1 对非小细胞肺癌患者生存预测的最佳截断值。
Anticancer Res. 2010 Sep;30(9):3833-7.
4
Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.表皮生长因子受体通路抑制在非小细胞肺癌中的一、二线治疗策略。
Expert Rev Anticancer Ther. 2010 Oct;10(10):1589-99. doi: 10.1586/era.10.104.
5
sFas levels increase in response to cisplatin-based chemotherapy in lung cancer patients.sFas 水平在肺癌患者接受顺铂为基础的化疗后会升高。
Cell Biochem Funct. 2010 Oct;28(7):565-70. doi: 10.1002/cbf.1689.
6
Posttranscriptional Regulation of Cyclooxygenase 2 Expression in Colorectal Cancer.结直肠癌中环氧合酶2表达的转录后调控
Curr Colorectal Cancer Rep. 2010 Apr;6(2):60-67. doi: 10.1007/s11888-010-0044-3.
7
Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.环氧化酶-2变体与吸烟在胰腺癌中的相互作用:核磷蛋白的可能作用
Gastroenterology. 2009 May;136(5):1659-68. doi: 10.1053/j.gastro.2009.01.071.
8
Morbidity and mortality in relation to smoking among women and men of Chinese ethnicity: the Singapore Chinese Health Study.华裔女性和男性吸烟相关的发病率和死亡率:新加坡华裔健康研究
Eur J Cancer. 2008 Jan;44(1):100-9. doi: 10.1016/j.ejca.2007.10.015. Epub 2007 Nov 19.
9
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.环氧化酶-2中功能性基因变异的鉴定及其与食管癌风险的关联。
Gastroenterology. 2005 Aug;129(2):565-76. doi: 10.1016/j.gastro.2005.05.003.
10
A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.环氧化酶2/前列腺素合成酶2基因3'非翻译区的常见多态性与中国人群肺癌风险
Lung Cancer. 2005 Apr;48(1):11-7. doi: 10.1016/j.lungcan.2004.09.004.